课题基金 / 基金详情

Inducing oxidative stress as a mechanism to increase the clinical impact of complex I inhibitors in treating aggressive breast cancers.

Inducing oxidative stress as a mechanism to increase the clinical impact of complex I inhibitors in treating aggressive breast cancers.
诱导氧化应激作为增加复合物 I 抑制剂治疗侵袭性乳腺癌临床影响的机制。
批准号：
455845
负责人：
Ursini-Siegel Giuseppina
金额：
$7.29万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-09-01 至 2022-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=455845&lang=en
关键词：
Breast Cancer Complex I Inhibitor Oxidative Stress Patient Derived Xenografts Pre-Clinical Models Ros Scavengers Targeted Therapies Tumor Metabolism

项目摘要

项目成果

Ursini-Siegel Giuseppina的其他基金

相关文献

中文摘要
翻译
尽管我们治疗一些乳腺癌的能力有了显著的改善，但有很大一部分女性在被诊断出患有这种疾病时，存活的可能性很低。对于患上更具侵袭性的乳腺癌的女性来说尤其如此
英文摘要
Despite significant improvements in our ability to treat some breast cancers, a significant subset of women retain a poor likelihood of survival when diagnosed with this disease. This is especially true for women who develop more aggressive breast cancer
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Capitalizing on an oxidative stress response to sensitize poor outcome cancers to PARP inhibitors
Understanding how oxidative stress influences tumor evolution via metabolic reprogramming
Defining the mechanisms and therapeutic potential of ShcA-mediated angiogenesis and metabolism that fuel breast tumorigenesis
Defining the Molecular Mechanisms and Clinical Implications of p66ShcA as a Driver of the Epithelial to Mesenchymal Transition in Breast Cancer